A: GHK-CU 50mg is used as a copper-binding research peptide in laboratory investigations examining skin biology, wound healing models, collagen and extracellular matrix dynamics, angiogenesis signalling, anti-inflammatory mechanisms, hair follicle biology, and gene expression modulation
Researchers who work with the broader class of repair peptides including TB-500, GHK-Cu, and KPV note that the BPC-157 peptides documentation extends further back than most synthetic alternatives, with published mechanistic research dating to the early 1990s
For patients with compromised immunity or those in integrative cancer support programs, this added immune capability can be an important part of the overall strategy
This 92-person trial is the closest thing to a head-to-head decomposition of the combination that exists, and its most interesting result is the negative one: on the primary glycaemic endpoint, adding cagrilintide to semaglutide did not produce a statistically significant improvement over semaglutide alone
This page explains the idea behind the stack, its separate-vial schedule, the math for both vials, key risks, and how it compares with other retatrutide stacks